30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Rock Edwin

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 30% 8.2% 15.1%
Success rate 88% 68% 82%
Transactions
7 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Rock Edwin's trades of Crescent Biopharma Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-24 2024-06-21
B Purchase
80,925 -36.0%
448.54
US$3,402,835 		80,925 -36.0% 448.54 US$3,402,835
2024-06-24 2024-06-20
B Purchase
81,920 +35.7%
42.59
US$1,303,409 		81,920 +35.7% 42.59 US$1,303,409
2023-09-25 2023-09-22
B Purchase
15,375 +44.7%
324.15
US$1,349,145 		15,375 +44.7% 324.15 US$1,349,145
2023-09-25 2023-09-21
B Purchase
35,000 +11.3%
1.38
US$48,300 		35,000 +11.3% 1.38 US$48,300
2022-12-27 2022-12-22
B Purchase
110,000 +55.0%
2.25
US$247,500 		110,000 +55.0% 2.25 US$247,500
2022-11-16 2022-11-15
B Purchase
100,000 +100.0%
1.66
US$166,000 		100,000 +100.0% 1.66 US$166,000
2022-11-16 2022-11-14
B Purchase
100,000 +inf%
1.43
US$143,000 		100,000 +inf% 1.43 US$143,000